Exports In 2022, Liberia exported $4.84k in Vaccines, blood, antisera, toxins and cultures, making it the 171st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 159th most exported product in Liberia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Liberia are: Spain ($3.6k), South Africa ($1.06k), Belgium ($183), and Canada ($1).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Liberia between 2021 and 2022 were Spain ($3.6k), South Africa ($1.06k), and Canada ($1).
Imports In 2022, Liberia imported $14.1M in Vaccines, blood, antisera, toxins and cultures, becoming the 155th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 33rd most imported product in Liberia. Liberia imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($5.65M), Germany ($3.22M), Belgium ($2.9M), India ($1.33M), and South Korea ($403k).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Liberia between 2021 and 2022 were Germany ($3.22M), United States ($860k), and Japan ($182k).